Monon Bioventures LLC

Indianapolis, IN

UEI
QFPDHTYDGBL1
CAGE
7E7M0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
1800 N Capitol Ave e504, Indianapolis, IN 46202, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Off-the-shelf engineered NK cells to treat glioblastoma R43CA271914 National Cancer Institute (NIH) $797,332
Soluble, solution-stable phospho-glucagon for hypoglycemic rescue R44DK121594 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $2,307,563
A novel probiotic platform to treat necrotizing enterocolitis R41GM122130 National Institute of General Medical Sciences (NIH) $331,395

Quick answers

Is Monon Bioventures LLC registered in SAM.gov?

Yes. Monon Bioventures LLC's SAM.gov registration is active through January 28, 2027.

What is Monon Bioventures LLC's most recent federal award?

Monon Bioventures LLC's most recent federal grant award is Off-the-shelf engineered NK cells to treat glioblastoma (R43CA271914), from National Cancer Institute (NIH), on August 1, 2022.

On GovTribe

See Monon Bioventures LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login